Denial rates in New York pulmonary practices run higher than national benchmarks — and not because New York pulmonologists are billing incorrectly in ways that other states do not. They run higher because New York’s payer environment is more demanding, more variable, and more administratively complex than what most billing workflows are designed to handle.
The result is a revenue cycle that leaves money on the table at multiple points: at the front end through eligibility and authorization errors, in the middle through documentation gaps and charge capture failures, and at the back end through denials that age unworked past the point of recovery. Each of these leakage points is addressable. None of them require a technology overhaul or a complete billing department restructure. They require the right workflows, applied consistently, with payer-specific knowledge driving the decisions.
This post is a practical guide to denial reduction and revenue recovery for New York pulmonary practices. It addresses the specific leakage points that AR reviews consistently surface in this market, the workflow changes that eliminate them, and the recovery strategies that recapture revenue from denials that have already accumulated.
Step One: Know Where Your Denials Are Coming From
Denial reduction starts with denial analysis — not with process changes. Practices that implement workflow changes before understanding their denial patterns will address the wrong problems and miss the ones that are driving the most revenue loss.
The analysis needs to answer four questions: Which payers are generating the most denials by volume? Which procedure categories have the highest denial rates? What are the primary denial reason codes, and do they reflect authorization issues, documentation issues, eligibility errors, or billing errors? And how old are the denials in your current worklist — what percentage are already past the point where recovery is likely?
For New York pulmonary practices, the answers to these questions typically reveal a concentrated denial pattern. Empire BCBS and New York Medicaid managed care plans account for a disproportionate share of denials relative to their share of claim volume. Pulmonary function testing, bronchoscopy, sleep diagnostics, and biologic authorizations have materially higher denial rates than office visits and routine evaluation and management services. And a significant percentage of the denial worklist — often 30 to 40 percent — has already aged past 60 days, where collection probability has fallen to 28 to 40 percent.
That concentrated pattern tells you where to focus. Fixing the authorization and documentation workflow for Empire BCBS bronchoscopy denials, for example, will have a measurable revenue impact because that is where the dollars are concentrated. Fixing eligibility verification for Medicaid managed care will eliminate a high-volume category of entirely preventable denials. The analysis makes the priority clear.
Front-End Denial Prevention: Where the Most Revenue Is Protected
The most efficient denial management is prevention — ensuring that claims submit correctly the first time, without authorization gaps, eligibility errors, or documentation deficiencies that will generate a denial weeks later. For New York pulmonary practices, front-end prevention requires four specific workflow elements.
Real-Time Eligibility Verification with MCO Specificity
Every patient appointment must be preceded by eligibility verification that confirms not just insurance coverage, but the specific plan and MCO enrollment relevant to claim routing. For Medicaid patients, this means confirming MCO enrollment through ePACES — not relying on the patient’s insurance card or verbal confirmation. For Empire BCBS patients, this means confirming which Empire product the patient is enrolled in, because Empire’s HMO, PPO, EPO, and ASO products have different networks, different authorization requirements, and different benefit structures.
Eligibility verification at scheduling — not at check-in, and not at billing — creates the time needed to identify coverage problems before the service is rendered. A patient whose Medicaid MCO enrollment has lapsed, whose Empire policy has changed to a plan the practice is not in-network with, or whose employer has switched insurance carriers can be addressed before the appointment — not after the claim denies.
Payer-Specific Prior Authorization at the Point of Scheduling
Authorization decisions for pulmonary procedures must be made using a current, payer-specific reference that accounts for Empire’s authorization requirements, each Medicaid MCO’s authorization requirements, and the requirements of other major commercial payers in the practice’s payer mix. A single authorization checklist that does not distinguish between payers will produce consistent authorization gaps for the payers whose requirements differ from the general standard.
The authorization reference must be maintained actively — updated when payer policy bulletins are issued, reviewed quarterly against each payer’s current coverage policies, and accessible to the staff member making the scheduling decision. Authorization requirements that live in a binder that has not been updated since the last staff turnover are not a workflow — they are a liability.
Documentation Templates Built Around Payer Criteria
Clinical documentation that supports clean claim submission for high-denial procedure categories must be structured to meet the specific medical necessity criteria of the payers most likely to review it. For Empire BCBS pulmonary function testing, this means documentation that addresses the specific clinical question, the patient’s relevant history, and the rationale for the test. For New York Medicaid managed care bronchoscopy, this means documentation that establishes the indication, the expected clinical impact, and the absence of less invasive alternatives where the plan requires that consideration.
Documentation templates that are built around payer criteria — and used consistently by all providers in the practice — create documentation that survives medical necessity review on first submission. They also create documentation that supports successful appeals when claims do deny, because the clinical record already contains what the payer’s reviewer needs to see.
Pre-Submission Claim Scrubbing with Payer-Specific Edit Rules
Every claim should be reviewed against payer-specific edit rules before submission. This includes confirming that the authorization number is present and correct for claims requiring authorization, that the place-of-service code matches the actual service location, that modifiers are applied correctly for the setting and the payer, and that the diagnosis codes support the procedure codes being billed under that payer’s coverage policies.
For New York pulmonary practices billing across 15 to 25 payer entities, a single scrubbing rule set is insufficient. The scrubbing rules for Empire BCBS differ from those for Healthfirst, which differ from those for United Healthcare. Billing systems that support payer-specific edit configurations allow practices to apply the right rules to each payer automatically — catching errors that a generic scrub would miss.
Mid-Cycle Denial Management: Working Denials Before They Age
Front-end prevention reduces denial volume. It does not eliminate it. The claims that do deny must be worked quickly, by an assigned owner, with a payer-specific action plan — not placed in a general queue where they will age past the recovery window.
Denial Triage and Priority Assignment
Every denial that enters the worklist should be triaged within 48 hours of receipt. Triage assigns a priority level based on the denial reason code, the payer’s appeal deadline, and the dollar value of the claim. High-value claims with short appeal windows get worked first. Authorization-related denials — which require payer engagement to resolve — get assigned to staff with authorization management experience. Documentation-related denials get routed to the clinical documentation team for physician query.
The triage step is where most New York pulmonary practices lose ground. Without triage, denials enter a single queue and are worked in order of receipt — a system that treats a $150 office visit denial and a $3,000 bronchoscopy denial with the same urgency. The high-value denial waits while lower-value claims are worked, and by the time it is reached, the appeal window may have narrowed significantly.
Root Cause Analysis at the Denial Category Level
Individual denial resolution recovers individual claims. Root cause analysis at the denial category level — understanding why a category of denials is occurring and fixing the underlying process — prevents the next wave. The two activities are not substitutes for each other. Practices that do only individual resolution will work the same denials month after month. Practices that do only root cause analysis without working individual denials will identify problems they never recover revenue from.
The root cause analysis question for each denial category is: what in our pre-service, clinical, or billing workflow created this denial, and what change would prevent it from recurring? For Empire BCBS sleep diagnostic denials, the root cause may be documentation that does not address pre-test probability — and the fix is a documentation template change. For Medicaid MCO routing errors, the root cause may be eligibility verification that does not confirm MCO enrollment — and the fix is a ePACES verification requirement at scheduling.
Payer-Specific Appeal Construction
Appeals for New York pulmonary denials succeed when they are built around the payer’s own criteria. For Empire BCBS, this means citing Empire’s Clinical Coverage Guidelines or Medical Policy Bulletins and demonstrating that the denied service meets the criteria in those documents. For New York Medicaid managed care, this means citing the MCO’s coverage policy and the New York State Medicaid coverage guidelines that the MCO is contractually required to follow.
Appeals that argue clinical appropriateness in general terms — “this service was medically necessary because the patient has COPD and required diagnostic evaluation” — do not address the payer’s specific denial rationale and will not succeed at the rate that payer-specific appeals do. Building payer-specific appeal templates for the denial categories that recur most frequently in the practice’s worklist is a one-time investment that improves appeal success rates on an ongoing basis.
For denials that survive internal appeal, New York’s external appeal process — governed by the Department of Financial Services for commercial plans and by the State’s fair hearing process for Medicaid — provides an independent review pathway. New York’s external appeal overturn rate for medical necessity denials is among the highest in the country, which means practices that pursue external review on appropriate cases recover meaningful revenue that would otherwise be written off.
Revenue Recovery: What to Do About the Denials Already in Your AR
Most New York pulmonary practices reading this post have a denial inventory that includes a significant percentage of aged denials — claims that have been sitting unworked for 30, 60, or more than 90 days. Some of those denials are recoverable. Some are not. Knowing which is which, and prioritizing recovery efforts accordingly, is the foundation of an effective AR recovery program.
AR Segmentation for Recovery Prioritization
The first step in AR recovery is segmenting the denial inventory by recoverability. Denials within the appeal window with a documented denial reason code and a claim value above a defined threshold are the highest-priority recovery targets. Denials past the appeal window but within the timely filing window for resubmission after correction are the second tier. Denials past both the appeal window and the timely filing window require a waiver or hardship request and should be assessed individually for whether the recovery effort is worth the investment.
For New York Medicaid managed care denials, it is worth confirming the MCO’s specific appeal timeline before writing off aged denials. Some MCOs’ appeal windows are longer than the standard 90-day period — and some claims that appear to be past the appeal deadline may still be recoverable under the MCO’s specific contract terms. A blanket write-off policy based on denial age without confirming payer-specific appeal windows leaves recoverable revenue on the table.
Underpayment Identification and Recovery
Not all revenue leakage takes the form of denied claims. For New York pulmonary practices, a systematic review of paid claims against contracted fee schedules frequently reveals underpayments that have been accepted as payment in full — because the payment posting process does not include a contracted rate comparison.
Empire BCBS underpayments are most commonly found in complex procedure categories where bundling logic or fee schedule updates have resulted in payments below the contracted rate. New York Medicaid managed care underpayments are frequently associated with carve-out services — specific services that are carved out of the managed care plan and should be billed to the carve-out entity rather than the MCO, but are billed to the MCO and paid at the wrong rate.
Underpayment disputes with commercial payers in New York must be filed within the payer’s prompt pay dispute timeline — typically 60 to 90 days from the date of payment. Underpayments that are not identified within that window may not be recoverable through the standard dispute process. Regular payment variance monitoring — comparing paid amounts against contracted amounts by procedure and by payer — is the only way to identify underpayments within the recovery window.
Charge Capture Review for Unbilled Services
Revenue leakage from unbilled services — services documented in the clinical record but never charged — is a consistent finding in AR reviews of New York pulmonary practices, particularly for hospital-based and inpatient services. A retrospective charge capture review of the past 90 days of clinical documentation, compared against billed charges, will identify services that were rendered and documented but never entered into the billing system.
For inpatient critical care encounters where charge lag is highest, this review frequently surfaces critical care time that was documented at a level supporting 99291 and 99292 billing but was billed at a lower-level hospital visit code — either because the billing staff did not recognize the critical care documentation or because the provider did not indicate critical care on the charge ticket. Each instance of critical care underbilling represents a revenue loss of $150 to $300 or more per encounter, and the pattern across multiple providers over 90 days can represent a significant recovery opportunity.
Measuring Revenue Cycle Performance in the New York Market
New York pulmonary practices need benchmarks that account for their market complexity. A denial rate that would be considered excellent for a single-payer primary care practice in a less complex market may be entirely inadequate for a multi-setting New York pulmonology practice billing across 20 payer entities with a high Medicaid volume.
The metrics that matter most for New York pulmonary RCM performance are denial rate by payer and by procedure (not just aggregate denial rate), average denial age in the worklist, appeal success rate by payer and by denial reason code, days in AR by payer, and underpayment rate by procedure category. These metrics reveal the payer-specific and procedure-specific patterns that aggregate metrics obscure — and they point directly to where the workflow changes will have the most impact.
Practices that report only aggregate metrics to leadership — overall denial rate, overall days in AR, overall collection rate — are managing their revenue cycle with insufficient resolution. The problems are concentrated in specific payer-procedure combinations. Finding and fixing those concentrations requires metrics specific enough to reveal them.
Monthly reporting of payer-specific and procedure-specific metrics to practice leadership — not just to the billing department — creates organizational visibility into revenue cycle performance that drives the resource allocation decisions needed to address systemic problems. When leadership can see that Empire BCBS bronchoscopy denials increased 20 percent quarter over quarter, they can authorize the workflow change and the staff training needed to address it.
What High-Performing New York Pulmonary Practices Do Differently
The New York pulmonary practices that consistently outperform their peers on revenue cycle metrics share a set of operational characteristics that distinguish them from practices struggling with the same payer environment.
- They treat billing as a clinical workflow issue, not just an administrative one. Authorization decisions, documentation standards, and charge capture are integrated into the clinical workflow — not handled entirely downstream by billing staff after the clinical encounter is complete.
- They maintain payer-specific knowledge as an organizational asset. Empire’s current medical policies, each Medicaid MCO’s authorization requirements, and the billing rules for workers’ compensation and no-fault are documented, accessible, and updated when policies change — not stored in individual staff members’ institutional memory.
- They measure denial performance at the payer-procedure level. Aggregate metrics tell them how they are doing overall. Payer-specific and procedure-specific metrics tell them where the problems are and what is causing them.
- They work denials fast, with assigned owners and escalation thresholds. High-value denials are worked within 48 hours of receipt. Appeal deadlines are tracked by payer. Denials approaching the appeal window without resolution are escalated — not left in a queue.
- They pursue external review for appropriate cases. New York’s external appeal process is a recovery tool that most practices underuse. High-performing practices know which denial categories have strong external review overturn rates and pursue that pathway systematically for cases that meet the criteria.
How PulmoCare RCM Helps New York Pulmonary Practices Reduce Denials and Recover Revenue
PulmoCare RCM provides denial reduction and revenue recovery services specifically for pulmonary and critical care practices in New York. Our approach starts with an AR review that identifies your denial concentration by payer and procedure, quantifies the revenue impact, and prioritizes the workflow changes that will have the fastest and largest impact on your collections.
We build the front-end prevention workflows, the denial management processes, and the payer-specific appeal strategies that reduce denial volume and improve appeal recovery rates — using knowledge of Empire BCBS, New York Medicaid managed care, and the full range of payers in the New York market.
If your New York pulmonary practice is losing revenue to denials and you are ready to understand exactly where it is going and how to stop it, reach out to PulmoCare RCM for a complimentary AR review and consultation.